Skip to main content
SpringerLink
Log in

Caspase-1 Mediates Fas-Induced Apoptosis and is Up-Regulated by Interferon-γ in Human Astrocytoma Cells

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Resistance to Fas-mediated apoptosis contributes to tumor evasion from the host immune system and enables tumors to mediate alternative responses such as inflammation and angiogenesis. In this study, we investigated the molecular mechanisms of the resistance to Fas-mediated apoptosis and sensitization to Fas-induced cell death by IFN-γ in human astrocytoma cells. To address this, we investigated the expression of thirty-three genes related to the Fas signal transduction pathways using RNase protection assay in five different human astrocytoma cells. Patterns of expression of these genes were similar between different cell lines and did not correlate with sensitivity to Fas-mediated cell death. Treatment with IFN-γ increased the mRNA expression of caspases-1, -4 and -7 in addition to those of Fas and TRAIL in a time- and dose-dependent manner. Studies using specific caspase inhibitors showed that Fas-induced cell death was mediated by caspases-1, -3 and 8 in the Fas-sensitive human astrocytoma cell lines, CRT-J and U87-MG. We further demonstrated that these caspases were proteolytically cleaved upon Fas ligation in these cells. Interestingly, caspase-1 protein expression but not that of caspase-3 nor -8 was up-regulated by IFN-γ only in Fas-sensitive CRT-J cells but not in Fas-resistant U373-MG cells. These results collectively suggest that caspase-1, along with caspases-3 and -8, mediate Fas-induced cell death in human astrocytoma cells, and post-transcriptional regulation of caspase-1 may determine the responsiveness to IFN-γ-induced sensitization to Fas-mediated apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gurney JG, Kadan-Lottick N: Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol 13: 160–166, 2001

    Article  CAS  PubMed  Google Scholar 

  2. Surawicz TS, Davis F, Freels S, Laws ER, Jr, Menck HR: Brain tumor survival: results from the National Cancer Data Base. J Neuro-Oncol 40: 151–160, 1998

    Article  CAS  Google Scholar 

  3. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP: Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17: 331–367, 1999

    Article  CAS  PubMed  Google Scholar 

  4. Nagata S: Fas ligand-induced apoptosis. Annu Rev Genet 33: 29–55, 1999

    Article  CAS  PubMed  Google Scholar 

  5. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F: The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184: 1075–1082, 1996

    PubMed  Google Scholar 

  6. Cefai D, Favre L, Wattendorf E, Marti A, Jaggi R, Gimmi CD: Role of Fas ligand expression in promoting escape from immune rejection in a spontaneous tumor model. Int J Cancer 91: 529–537, 2001

    CAS  PubMed  Google Scholar 

  7. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A: Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94: 954–964, 1994

    CAS  PubMed  Google Scholar 

  8. Husain N, Chiocca EA, Rainov N, Louis DN, Zervas NT: Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines. Acta Neuropathol (Berl) 95: 287–290, 1998

    CAS  Google Scholar 

  9. Gratas C, Tohma Y, Van Meir EG, Klein M, Tenan M, Ishii N, Tachibana O, Kleihues P, Ohgaki H: Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors. Brain Pathol 7: 863–869, 1997

    CAS  PubMed  Google Scholar 

  10. Ichinose M, Masuoka J, Shiraishi T, Mineta T, Tabuchi K: Fas ligand expression and depletion of T-cell infiltration in astrocytic tumors. Brain Tumor Pathol 18: 37–42, 2001

    CAS  PubMed  Google Scholar 

  11. Saas P, Walker PR, Hahne M, Quiquerez AL, Schnuriger V, Perrin G, French L, Van Meir EG, de Tribolet N, Tschopp J, Dietrich PY: Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J Clin Invest 99: 1173–1178, 1997

    CAS  PubMed  Google Scholar 

  12. Shinohara H, Yagita H, Ikawa Y, Oyaizu N: Fas drives cell cycle progression in glioma cells via extracellular signalregulated kinase activation. Cancer Res 60: 1766–1772, 2000

    CAS  PubMed  Google Scholar 

  13. Choi C, Gillespie GY, VanWagoner NJ, Benveniste EN: Fas engagement increases expression of Interleukin-6 in human glioma cells. J Neuro-Oncol 56: 13–19, 2002

    Article  Google Scholar 

  14. Choi C, Kutsch O, Park JS, Zhou T, Seol DW, Benveniste EN: Tumor necrosis factor related apoptosis inducing ligand (TRAIL) induces caspase-dependent Interleukin-8 expression and apoptosis in human astroglioma cells. Mol Cell Biol 22: 724–736, 2002

    CAS  PubMed  Google Scholar 

  15. Choi C, Xu X, Oh JW, Lee SJ, Gillespie GY, Park H, Jo H, Benveniste EN: Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signalregulated kinase 1/2 and p38 mitogen-activated protein kinase. Cancer Res 61: 3084–3091, 2001

    CAS  PubMed  Google Scholar 

  16. Talmadge JE, Tribble HR, Pennington RW, Phillips H, Wiltrout RH: Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice. Cancer Res 47: 2563–2570, 1987

    CAS  PubMed  Google Scholar 

  17. Saito T, Berens ME, Welander CE: Direct and indirect effects of human recombinant gamma-interferon on tumor cells in a clonogenic assay. Cancer Res 46: 1142–1147, 1986

    CAS  PubMed  Google Scholar 

  18. Koshiji M, Adachi Y, Sogo S, Taketani S, Oyaizu N, Than S, Inaba M, Phawa S, Hioki K, Ikehara S: Apoptosis of colorectal adenocarcinoma (COLO 201) by tumour necrosis factor-alpha (TNF-alpha) and/or interferon-gamma (IFN-gamma), resulting from down-modulation of Bcl-2 expression. Clin Exp Immunol 111: 211–218, 1998

    Article  CAS  PubMed  Google Scholar 

  19. Spanaus KS, Schlapbach R, Fontana A: TNF-alpha and IFN-gamma render microglia sensitive to Fas ligandinduced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL. Eur J Immunol 28: 4398–4408, 1998

    Article  CAS  PubMed  Google Scholar 

  20. Ossina NK, Cannas A, Powers VC, Fitzpatrick PA, Knight JD, Gilbert JR, Shekhtman EM, Tomei LD, Umansky SR, Kiefer MC: Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 272: 16351–16357, 1997

    Article  CAS  PubMed  Google Scholar 

  21. Weller M, Malipiero U, Rensing-Ehl A, Barr PJ, Fontana A: Fas/APO-1 gene transfer for human malignant glioma. Cancer Res 55: 2936–2944, 1995

    CAS  PubMed  Google Scholar 

  22. Van Wagoner NJ, Choi C, Repovic P, Benveniste EN: OncostatinMregulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38. J Neurochem 75: 563–575, 2000

    Article  CAS  PubMed  Google Scholar 

  23. Xu X, Fu XY, Plate J, Chong AS: IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res 58: 2832–2837, 1998

    CAS  PubMed  Google Scholar 

  24. Choi C, Park JY, Lee J, Lim JH, Shin EC, Ahn YS, Kim CH, Kim SJ, Kim JD, Choi IS, Choi IH: Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J Immunol 162: 1889–1895, 1999

    CAS  PubMed  Google Scholar 

  25. Chang HY, Yang X: Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev 64: 821–846, 2000

    CAS  PubMed  Google Scholar 

  26. Shin EC, Ahn JM, Kim CH, Choi Y, Ahn YS, Kim H, Kim SJ, Park JH: IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway. Int J Cancer 93: 262–268, 2001

    Article  CAS  PubMed  Google Scholar 

  27. Dai C, Krantz SB: Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood 93: 3309–3316, 1999

    CAS  PubMed  Google Scholar 

  28. Ruiz-Ruiz C, Munoz-Pinedo C, Lopez-Rivas A: Interferongamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program. Cancer Res 60: 5673–5680, 2000

    CAS  PubMed  Google Scholar 

  29. Lin XY, Choi MS, Porter AG: Expression analysis of the human caspase-1 subfamily reveals specific regulation of the CASP5 gene by lipopolysaccharide and interferon-gamma. J Biol Chem 275: 39920–39926, 2000

    CAS  PubMed  Google Scholar 

  30. Tran SE, Holmstrom TH, Ahonen M, Kahari VM, Eriksson JE: MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J Biol Chem 276: 16484–16490, 2001

    Article  CAS  PubMed  Google Scholar 

  31. Holmstrom TH, Schmitz I, Soderstrom TS, Poukkula M, Johnson VL, Chow SC, Krammer PH, Eriksson JE: MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO J 19: 5418–5428, 2000

    Article  CAS  PubMed  Google Scholar 

  32. Gibson S, Tu S, Oyer R, Anderson SM, Johnson GL: Epidermal growth factor protects epithelial cells against Fasinduced apoptosis. Requirement for Akt activation. J Biol Chem 274: 17612–17618, 1999

    CAS  PubMed  Google Scholar 

  33. Di Cristofano A, Kotsi P, Peng YF, Cordon-Cardo C, Elkon KB, Pandolfi PP: Impaired Fas response and autoimmunity in Pten+/-mice. Science 285: 2122–2125, 1999

    Article  CAS  PubMed  Google Scholar 

  34. Panka DJ, Mano T, Suhara T, Walsh K, Mier JW: Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J Biol Chem 276: 6893–6896, 2001

    Article  CAS  PubMed  Google Scholar 

  35. Suzuki A, Hayashida M, Kawano H, Sugimoto K, Nakano T, Shiraki K: Hepatocyte growth factor promotes cell survival from fas-mediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression. Hepatology 32: 796–802, 2000

    CAS  PubMed  Google Scholar 

  36. Holmstrom TH, Tran SE, Johnson VL, Ahn NG, Chow SC, Eriksson JE: Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis. Mol Cell Biol 19: 5991–6002, 1999

    CAS  PubMed  Google Scholar 

  37. Baud V, Karin M: Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11: 372–377, 2001

    Article  CAS  PubMed  Google Scholar 

  38. Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 281: 1312–1316, 1998

    Article  CAS  PubMed  Google Scholar 

  39. Keane MM, Ettenberg SA, Lowrey GA, Russell EK, Lipkowitz S: Fas expression and function in normal and malignant breast cell lines. Cancer Res 56: 4791–4798, 1996

    CAS  PubMed  Google Scholar 

  40. Wilson KP, Black JA, Thomson JA, Kim EE, Griffith JP, Navia MA, Murcko MA, Chambers SP, Aldape RA, Raybuck SAet al.: Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370: 270–275, 1994

    Article  CAS  PubMed  Google Scholar 

  41. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, Wong W, Kamen R, Tracey D, Allen H: Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386: 619–623, 1997

    Article  CAS  PubMed  Google Scholar 

  42. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimoto M, Tanimoto T, Flavell RA, Sato V, Harding MW, Livingston DJ, Su MS: Activation of interferon-gamma inducing factor mediated by interleukin-1 beta converting enzyme. Science 275: 206–209, 1997

    CAS  PubMed  Google Scholar 

  43. Detjen KM, Farwig K, Welzel M, Wiedenmann B, Rosewicz S: Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis. Gut 49: 251–262, 2001

    Article  CAS  PubMed  Google Scholar 

  44. Tatsuta T, Shiraishi A, Mountz JD: The prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activation. J Biol Chem 275: 14248–14254, 2000

    Article  CAS  PubMed  Google Scholar 

  45. Ueki T, Takeuchi T, Nishimatsu H, Kajiwara T, Moriyama N, Narita Y, Kawabe K, Ueki K, Kitamura T:Silencing of the caspase-1 gene occurs in murine and human renal cancer cells and causes solid tumor growth in vivo. Int J Cancer 91: 673–679, 2001

    Article  CAS  PubMed  Google Scholar 

  46. Dinarello CA: Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N Y Acad Sci 856: 1–11, 1998

    Article  CAS  PubMed  Google Scholar 

  47. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J et al.: Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80: 401–411, 1995

    CAS  PubMed  Google Scholar 

  48. Li M, Ona VO, Guegan C, Chen M, Jackson-Lewis V, Andrews LJ, Olszewski AJ, Stieg PE, Lee JP, Przedborski S, Friedlander RM: Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288: 335–339, 2000

    CAS  PubMed  Google Scholar 

  49. Friedlander RM, Gagliardini V, Hara H, Fink KB, Li W, MacDonald G, Fishman MC, Greenberg AH, Moskowitz MA, Yuan J: Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J Exp Med 185: 933–940, 1997

    Article  CAS  PubMed  Google Scholar 

  50. Ona VO, Li M, Vonsattel JP, Andrews LJ, Khan SQ, Chung WM, Frey AS, Menon AS, Li XJ, Stieg PE, Yuan J, Penney JB, Young AB, Cha JH, Friedlander RM: Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399: 263–267, 1999

    CAS  PubMed  Google Scholar 

  51. Friedlander RM: Role of caspase 1 in neurologic disease. Arch Neurol 57: 1273–1276, 2000

    CAS  PubMed  Google Scholar 

  52. Friedlander RM, Yuan J: ICE, neuronal apoptosis and neurodegeneration. Cell Death Differ 5: 823–831, 1998

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Molecular Life Sciences and Center for Cell Signaling Research, Ewha Womans University, Seoul, Korea

    Chulhee Choi & Eunjoo Jeong

  2. Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL, USA

    Chulhee Choi & Etty N. Benveniste

Authors
  1. Chulhee Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eunjoo Jeong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Etty N. Benveniste
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choi, C., Jeong, E. & Benveniste, E.N. Caspase-1 Mediates Fas-Induced Apoptosis and is Up-Regulated by Interferon-γ in Human Astrocytoma Cells. J Neurooncol 67, 167–176 (2004). https://doi.org/10.1023/B:NEON.0000021896.52664.9e

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:NEON.0000021896.52664.9e

Search

Navigation